UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044406
Receipt number R000050687
Scientific Title Verification of Performance Improvement and Fatigue Reduction Effect by flossing for Athletes
Date of disclosure of the study information 2021/07/01
Last modified on 2022/12/03 12:20:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of Performance Improvement and Fatigue Reduction Effect by flossing for Athletes

Acronym

Verification of Performance Improvement and Fatigue Reduction Effect by flossing for Athletes

Scientific Title

Verification of Performance Improvement and Fatigue Reduction Effect by flossing for Athletes

Scientific Title:Acronym

Verification of Performance Improvement and Fatigue Reduction Effect by flossing for Athletes

Region

Japan


Condition

Condition

locomotor disorders

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to assess whether the fatigue reduction effect of flossing during competition will improve performance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Record of pitching, short splint, and running.

Key secondary outcomes

Muscle power


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Flossing

Interventions/Control_2

stretching

Interventions/Control_3

No treaatment

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Male

Key inclusion criteria

1) Athletes who regularly carry out pitching or 20m sprints, which is the evaluation event this time.
2) Athletes who have reached the adult age at the time of obtaining consent.
3) Athletes who received sufficient explanation before participating in this study, and after sufficient understanding, obtained the voluntary written consent of all the subjects.

Key exclusion criteria

1) All subjects with pain who need to take anti-inflammatory analgesics during evaluation exercise
2) All subjects who have a history of allergies to the materials of the test equipment
3) In addition, all the subjects who the principal investigator judged to be inappropriate as all the subjects

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tomonori
Middle name
Last name Kenmoku

Organization

Kitasato University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code

2520-374

Address

Kitazato 1-15-1 Minami-ku, Sagamihara city, Kanagawa

TEL

042-778-8111

Email

pseudolefty811@yahoo.co.jp


Public contact

Name of contact person

1st name Tomonori
Middle name
Last name Kenmoku

Organization

Kitasato University School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code

252-0374

Address

Kitazato 1-15-1 Minami-ku, Sagamihara city, Kanagawa

TEL

042-778-8111

Homepage URL


Email

pseudolefty811@yahoo.co.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery, Kitasato University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Sanct Japan Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kitasato University Department of Allied Health Sciences

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University Medical Ethics Organization for Clinical Research

Address

Kitazato 1-15-1 Minami-ku, Sagamihara city, Kanagawa

Tel

042-778-8111

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 06 Month 16 Day

Date of IRB

2021 Year 06 Month 29 Day

Anticipated trial start date

2021 Year 07 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 06 Month 02 Day

Last modified on

2022 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050687


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name